About
Tune Therapeutics develops targeted epigenetic editing technologies that regulate gene expression without altering DNA sequences, enabling novel treatments for chronic and age-related diseases.
Explore Tune Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.